ICPT
Intercept Pharmaceuticals Inc
Price:  
19.00 
USD
Volume:  
3,906,760.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICPT Relative Valuation

-239.4%
Upside

As of 2025-07-12, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (26.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -239.4%.

The range of the Relative Valuation is (21.99) - (30.44) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.6x - 25.0x 19.0x
Forward P/E multiples 14.9x - 20.7x 16.9x
Fair Price (21.99) - (30.44) (26.49)
Upside -215.7% - -260.2% -239.4%
19.00 USD
Stock Price
(26.49) USD
Fair Price

ICPT Relative Valuation - Historical P/E Data

Date P/E